n.d. - monograph
RxNorm 56188 (Sermorelin)
Unknown Authors.
Bibliography For Sermorelin
Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.
Indexed Types:monographstudy
n.d. - study
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Unknown Authors.
n.d. - study
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.
Unknown Authors.
n.d. - study
Rarely listed essential medicines in 158 national lists.
Unknown Authors.
n.d. - study
CDPMF-DDA: contrastive deep probabilistic matrix factorization for drug-disease association prediction.
Unknown Authors.
n.d. - study
Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literature.
Unknown Authors.
n.d. - study
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Unknown Authors.
n.d. - study
Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.
Unknown Authors.
n.d. - study
A potentially effective drug for patients with recurrent glioma: sermorelin.
Unknown Authors.
n.d. - study
Synthetic Peptides in Doping Control: A Powerful Tool for an Analytical Challenge.
Unknown Authors.
n.d. - study
Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer's disease models.
Unknown Authors.
n.d. - study
The Diagnostic Trap: When PSA Results Mislead - A Case Report.
Unknown Authors.
n.d. - study
Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Unknown Authors.
n.d. - study
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.
Unknown Authors.
n.d. - study
A novel approach for the treatment of AML, through GHRH antagonism: MIA-602.
Unknown Authors.
n.d. - study
Growth Hormone-Releasing Peptides: Investigation of Their Secondary Structure, Thermal Stability, and Model Membrane Interactions.
Unknown Authors.
n.d. - study
Probing for peptidic drugs (2-10 kDa) in doping control blood samples.
Unknown Authors.
n.d. - study
Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies.
Unknown Authors.
n.d. - study
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.
Unknown Authors.
n.d. - study
Recent Developments in Capillary and Microchip Electroseparations of Peptides (2023-mid 2025).
Unknown Authors.
n.d. - study
Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.
Unknown Authors.
n.d. - study
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Unknown Authors.
n.d. - study
Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR).
Unknown Authors.
n.d. - study
A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
Unknown Authors.
n.d. - study
Mesenchymal Stem cell therapy with GHRH receptor analog resolves post-stroke vasogenic edema via modulating AQP4 and mitochondria-ER crosstalk.
Unknown Authors.
n.d. - study
MultiPep: a hierarchical deep learning approach for multi-label classification of peptide bioactivities.
Unknown Authors.